Alemtuzumab Diminished MS Disability
MedPage Today,
Action Points Note that this secondary analysis of a randomized trial found that alemtuzumab was superior to placebo in terms…
Action Points Note that this secondary analysis of a randomized trial found that alemtuzumab was superior to placebo in terms…
Crino L, Scagliotti G, Marangolo M, Figoli F, Clerici M, De Marinis F, et al. Cisplatin-gemcitabine combination in advanced non-s…